Alkermes

Medical Director, Medical Affairs (Lifecycle Management)

Alkermes$270K — $305K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • MD with experience in Neurology or Psychiatry required.
  • Board Certification in Neurology or Psychiatry preferred.
  • Minimum 2+ years experience in pharmaceutical industry medical affairs/clinical development or LCM functions.
  • Business-focused with experience in drug development across late-stage clinical programs.
  • Experience with global regulatory agencies, including successful sNDA submissions and label expansions.
  • Outstanding written and verbal communication skills; experience presenting to senior management.
  • Ability to navigate complexity in a highly matrixed work environment.

Responsibilities

  • Design and execute clinical research protocols for neurologic disorders.
  • Lead multiple late-stage clinical programs as the LCM Lead.
  • Author protocols, clinical study reports, and regulatory documents directly.
  • Provide medical oversight and monitoring of clinical trial data with CRO partners.
  • Review and contribute to regulatory interactions for sNDAs and LCM studies.
  • Develop lifecycle management (LCM) plans with cross-functional teams.
  • Coordinate operational aspects of ongoing projects to meet time and quality goals.

Benefits

  • Hybrid work environment with flexibility for remote work 40% of the time.
  • Opportunity to influence drug development in high-impact therapeutic areas.
  • Participation in strategic discussions around lifecycle management and indications.
  • Collaborative work with global thought leaders and key investigators.
  • Engagement in presenting at major medical conferences and advisory boards.
Full Job Description
Job Description

This is a high impact position with great visibility, and collaboration, across multiple departments and all levels of the Alkermes organization. This position will have critical responsibilities in the medical affairs group involved in the development of therapies for neurology and neuropsychiatric indications across late-stage programs, contributing to Alkermes' LCM efforts in neuroscience.

Responsibilities

  • Responsible for protocol design and execution across late-stage clinical research trials in neurologic disorders
  • Serve as the LCM Lead for multiple programs, including leadership of the subteams of those programs
  • Direct authorship contributions in protocols, clinical study reports, study documents, regulatory documents, and external publications
  • Provide medical oversight of clinical trial data and medical monitoring (in conjunction with a CRO medical monitoring team) of clinical trials supporting sNDA indications and LCM studies
  • Critically review and contribute to regulatory interactions for LCM studies, sNDAs
  • Develop LCM plans with cross functional teams and contribute to strategic discussions related to LCM plans and indications
  • Develop strategy for Investigator Sponsored Studies (ISS) program with cross functional team members and serve on the ISS review committee as a reviewer
  • Responsible for strategy and execution of product specific global expanded access and compassionate use programs in collaboration with the EAP team
  • Represent the company to external audiences, including clinical sites, key opinion leaders, and patient advocacy groups
  • In collaboration with clinical operations, oversee and coordinate the operational aspects of ongoing projects to ensure that goals of time, cost and quality performance expectation are met
  • Ensure that standard operating procedures (SOP) for the LCM team facilitate the development of effective clinical research programs and are compliant with clinical/medical and industry standards
  • Identify and develop collaborative relationships with key investigators, and key thought leaders globally. Attend, plan, and oversee lifecycle management clinical advisory boards and investigator meetings, and present at major medical conferences


Qualifications

  • MD with experience in Neurology or Psychiatry required
  • Board Certification in Neurology or Psychiatry preferred
  • A minimum of 2+ years of experience in the pharmaceutical industry in medical affairs/ clinical development or LCM functions
  • A business-focused individual, with experience in all aspects of drug development across late-stage clinical programs
  • Experience interacting with global regulatory agencies, including successful sNDA submissions, label expansions and approvals is highly desired
  • Outstanding written and verbal communication, with experience interacting with and presenting to senior management and external audiences
  • Ability to navigate complexity and ambiguity in a highly matrixed work environment
  • Demonstrated leadership and collaborative interpersonal skills, fostering teamwork and cross-functional partnerships
  • Self-motivated with the ability to work independently, prioritize tasks efficiently, and meet deadlines
  • Detail-oriented with expertise in conducting thorough and timely reviews of medical and trial related documents

Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.

The annual base salary for this position ranges from $270,000 to $305,000. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here

#LI-MB1

About Alkermes

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders, and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. Alkermes was founded in 1987 and has approximately 2,000 employees.
Learn more about Alkermes
Size
2,211 employees
Market Cap
$4.1 billion
Industry
Net Income
-$110.8 million
Founded
2011
5 Year Trend
+9.5%
Revenue
$1 billion
NASDAQ

Similar Jobs

More Jobs at Alkermes

More Pharmaceuticals & Biotech Jobs

Find similar Medical Director, Medical Affairs (Lifecycle Management) jobs: